According to the article by the pharmaceutical journal, 17% of centrally-authorised chemical products have been identified at being at risk of nitrosamine contamination. And of those that had a risk identified, so far only 15% contained nitrosamines levels above the “acceptable intake” and will likely require a variation in their marketing authorisation. However, even a small percentage could relate to 20 or more products.
The Great Nitrosamine Audit: how many more drugs will disappear from our shelves?
I couldn’t open the attached file, please share it again.
I’m sorry, but the number of free articles in a month is limited. You can use another gadget like a mobile phone to access the article. Or, it will recover in May.
Anyway, I apologize for the inconvenience.